0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Influenza Drugs Market Size, Status and Forecast 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-12P3311
Home | Market Reports | Health | Pharmacy
Global and United States Influenza Drugs Market Size Status and Forecast 2021 2027

Global and United States Influenza Drugs Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-12P3311
Report
September 2021
117 Pages
QYResearch
Region: Global, Taiwan, Africa, France, Canada, Germany, Italy, Philippines, Turkey, Australia, India, South Korea, Mexico, Japan, China, Saudi Arabia, Vietnam, Malaysia, Thailand, Indonesia, Brazil,
Description
Table of Content
Tables & Figures
Global Influenza Drugs Scope and Market Size
Influenza Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Oseltamivir
Zanamivir
Peramivir
Other

Segment by Application

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oseltamivir
1.2.3 Zanamivir
1.2.4 Peramivir
1.2.5 Other
1.3 Market by Application
1.3.1 Global Influenza Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Influenza Drugs Market Perspective (2016-2027)
2.2 Influenza Drugs Growth Trends by Regions
2.2.1 Influenza Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Drugs Industry Dynamic
2.3.1 Influenza Drugs Market Trends
2.3.2 Influenza Drugs Market Drivers
2.3.3 Influenza Drugs Market Challenges
2.3.4 Influenza Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Drugs Players by Revenue
3.1.1 Global Top Influenza Drugs Players by Revenue (2016-2021)
3.1.2 Global Influenza Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Drugs Revenue
3.4 Global Influenza Drugs Market Concentration Ratio
3.4.1 Global Influenza Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Drugs Revenue in 2020
3.5 Influenza Drugs Key Players Head office and Area Served
3.6 Key Players Influenza Drugs Product Solution and Service
3.7 Date of Enter into Influenza Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Drugs Breakdown Data by Type
4.1 Global Influenza Drugs Historic Market Size by Type (2016-2021)
4.2 Global Influenza Drugs Forecasted Market Size by Type (2022-2027)
5 Influenza Drugs Breakdown Data by Application
5.1 Global Influenza Drugs Historic Market Size by Application (2016-2021)
5.2 Global Influenza Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Influenza Drugs Market Size (2016-2027)
6.2 North America Influenza Drugs Market Size by Type
6.2.1 North America Influenza Drugs Market Size by Type (2016-2021)
6.2.2 North America Influenza Drugs Market Size by Type (2022-2027)
6.2.3 North America Influenza Drugs Market Size by Type (2016-2027)
6.3 North America Influenza Drugs Market Size by Application
6.3.1 North America Influenza Drugs Market Size by Application (2016-2021)
6.3.2 North America Influenza Drugs Market Size by Application (2022-2027)
6.3.3 North America Influenza Drugs Market Size by Application (2016-2027)
6.4 North America Influenza Drugs Market Size by Country
6.4.1 North America Influenza Drugs Market Size by Country (2016-2021)
6.4.2 North America Influenza Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Influenza Drugs Market Size (2016-2027)
7.2 Europe Influenza Drugs Market Size by Type
7.2.1 Europe Influenza Drugs Market Size by Type (2016-2021)
7.2.2 Europe Influenza Drugs Market Size by Type (2022-2027)
7.2.3 Europe Influenza Drugs Market Size by Type (2016-2027)
7.3 Europe Influenza Drugs Market Size by Application
7.3.1 Europe Influenza Drugs Market Size by Application (2016-2021)
7.3.2 Europe Influenza Drugs Market Size by Application (2022-2027)
7.3.3 Europe Influenza Drugs Market Size by Application (2016-2027)
7.4 Europe Influenza Drugs Market Size by Country
7.4.1 Europe Influenza Drugs Market Size by Country (2016-2021)
7.4.2 Europe Influenza Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Influenza Drugs Market Size (2016-2027)
8.2 Asia-Pacific Influenza Drugs Market Size by Type
8.2.1 Asia-Pacific Influenza Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Drugs Market Size by Application
8.3.1 Asia-Pacific Influenza Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Drugs Market Size by Region
8.4.1 Asia-Pacific Influenza Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Influenza Drugs Market Size (2016-2027)
9.2 Latin America Influenza Drugs Market Size by Type
9.2.1 Latin America Influenza Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Drugs Market Size by Type (2016-2027)
9.3 Latin America Influenza Drugs Market Size by Application
9.3.1 Latin America Influenza Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Drugs Market Size by Application (2016-2027)
9.4 Latin America Influenza Drugs Market Size by Country
9.4.1 Latin America Influenza Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Drugs Market Size (2016-2027)
10.2 Middle East & Africa Influenza Drugs Market Size by Type
10.2.1 Middle East & Africa Influenza Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Drugs Market Size by Application
10.3.1 Middle East & Africa Influenza Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Drugs Market Size by Country
10.4.1 Middle East & Africa Influenza Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Influenza Drugs Introduction
11.1.4 Bristol-Myers Squibb Revenue in Influenza Drugs Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Influenza Drugs Introduction
11.2.4 AstraZeneca Revenue in Influenza Drugs Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Influenza Drugs Introduction
11.3.4 Eli Lilly Revenue in Influenza Drugs Business (2016-2021)
11.3.5 Eli Lilly Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Influenza Drugs Introduction
11.4.4 Roche Revenue in Influenza Drugs Business (2016-2021)
11.4.5 Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Influenza Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Influenza Drugs Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Influenza Drugs Introduction
11.6.4 Novartis Revenue in Influenza Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Influenza Drugs Introduction
11.7.4 Pfizer Revenue in Influenza Drugs Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Sanofi Pasteur
11.8.1 Sanofi Pasteur Company Details
11.8.2 Sanofi Pasteur Business Overview
11.8.3 Sanofi Pasteur Influenza Drugs Introduction
11.8.4 Sanofi Pasteur Revenue in Influenza Drugs Business (2016-2021)
11.8.5 Sanofi Pasteur Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Influenza Drugs Introduction
11.9.4 Bayer Revenue in Influenza Drugs Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Celgene
11.10.1 Celgene Company Details
11.10.2 Celgene Business Overview
11.10.3 Celgene Influenza Drugs Introduction
11.10.4 Celgene Revenue in Influenza Drugs Business (2016-2021)
11.10.5 Celgene Recent Development
11.11 Seqirus
11.11.1 Seqirus Company Details
11.11.2 Seqirus Business Overview
11.11.3 Seqirus Influenza Drugs Introduction
11.11.4 Seqirus Revenue in Influenza Drugs Business (2016-2021)
11.11.5 Seqirus Recent Development
11.12 Protein Sciences Corporation
11.12.1 Protein Sciences Corporation Company Details
11.12.2 Protein Sciences Corporation Business Overview
11.12.3 Protein Sciences Corporation Influenza Drugs Introduction
11.12.4 Protein Sciences Corporation Revenue in Influenza Drugs Business (2016-2021)
11.12.5 Protein Sciences Corporation Recent Development
11.13 Serum Institute of India
11.13.1 Serum Institute of India Company Details
11.13.2 Serum Institute of India Business Overview
11.13.3 Serum Institute of India Influenza Drugs Introduction
11.13.4 Serum Institute of India Revenue in Influenza Drugs Business (2016-2021)
11.13.5 Serum Institute of India Recent Development
11.14 Emergent Biosolutions
11.14.1 Emergent Biosolutions Company Details
11.14.2 Emergent Biosolutions Business Overview
11.14.3 Emergent Biosolutions Influenza Drugs Introduction
11.14.4 Emergent Biosolutions Revenue in Influenza Drugs Business (2016-2021)
11.14.5 Emergent Biosolutions Recent Development
11.15 BioCryst Pharmaceuticals
11.15.1 BioCryst Pharmaceuticals Company Details
11.15.2 BioCryst Pharmaceuticals Business Overview
11.15.3 BioCryst Pharmaceuticals Influenza Drugs Introduction
11.15.4 BioCryst Pharmaceuticals Revenue in Influenza Drugs Business (2016-2021)
11.15.5 BioCryst Pharmaceuticals Recent Development
11.16 Alvogen
11.16.1 Alvogen Company Details
11.16.2 Alvogen Business Overview
11.16.3 Alvogen Influenza Drugs Introduction
11.16.4 Alvogen Revenue in Influenza Drugs Business (2016-2021)
11.16.5 Alvogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Influenza Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Oseltamivir
    Table 3. Key Players of Zanamivir
    Table 4. Key Players of Peramivir
    Table 5. Key Players of Other
    Table 6. Global Influenza Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Influenza Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Influenza Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Influenza Drugs Market Share by Regions (2016-2021)
    Table 10. Global Influenza Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Influenza Drugs Market Share by Regions (2022-2027)
    Table 12. Influenza Drugs Market Trends
    Table 13. Influenza Drugs Market Drivers
    Table 14. Influenza Drugs Market Challenges
    Table 15. Influenza Drugs Market Restraints
    Table 16. Global Influenza Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Influenza Drugs Market Share by Players (2016-2021)
    Table 18. Global Top Influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs as of 2020)
    Table 19. Ranking of Global Top Influenza Drugs Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Influenza Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Influenza Drugs Product Solution and Service
    Table 23. Date of Enter into Influenza Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Influenza Drugs Revenue Market Share by Type (2016-2021)
    Table 27. Global Influenza Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Influenza Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Influenza Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Influenza Drugs Revenue Market Share by Application (2016-2021)
    Table 31. Global Influenza Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Influenza Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Influenza Drugs Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Influenza Drugs Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Influenza Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Influenza Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Influenza Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Influenza Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Influenza Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Influenza Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 63. Bristol-Myers Squibb Company Details
    Table 64. Bristol-Myers Squibb Business Overview
    Table 65. Bristol-Myers Squibb Influenza Drugs Product
    Table 66. Bristol-Myers Squibb Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 67. Bristol-Myers Squibb Recent Development
    Table 68. AstraZeneca Company Details
    Table 69. AstraZeneca Business Overview
    Table 70. AstraZeneca Influenza Drugs Product
    Table 71. AstraZeneca Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 72. AstraZeneca Recent Development
    Table 73. Eli Lilly Company Details
    Table 74. Eli Lilly Business Overview
    Table 75. Eli Lilly Influenza Drugs Product
    Table 76. Eli Lilly Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 77. Eli Lilly Recent Development
    Table 78. Roche Company Details
    Table 79. Roche Business Overview
    Table 80. Roche Influenza Drugs Product
    Table 81. Roche Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 82. Roche Recent Development
    Table 83. GlaxoSmithKline Company Details
    Table 84. GlaxoSmithKline Business Overview
    Table 85. GlaxoSmithKline Influenza Drugs Product
    Table 86. GlaxoSmithKline Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 87. GlaxoSmithKline Recent Development
    Table 88. Novartis Company Details
    Table 89. Novartis Business Overview
    Table 90. Novartis Influenza Drugs Product
    Table 91. Novartis Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 92. Novartis Recent Development
    Table 93. Pfizer Company Details
    Table 94. Pfizer Business Overview
    Table 95. Pfizer Influenza Drugs Product
    Table 96. Pfizer Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 97. Pfizer Recent Development
    Table 98. Sanofi Pasteur Company Details
    Table 99. Sanofi Pasteur Business Overview
    Table 100. Sanofi Pasteur Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 101. Sanofi Pasteur Recent Development
    Table 102. Bayer Company Details
    Table 103. Bayer Business Overview
    Table 104. Bayer Influenza Drugs Product
    Table 105. Bayer Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 106. Bayer Recent Development
    Table 107. Celgene Company Details
    Table 108. Celgene Business Overview
    Table 109. Celgene Influenza Drugs Product
    Table 110. Celgene Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 111. Celgene Recent Development
    Table 112. Seqirus Company Details
    Table 113. Seqirus Business Overview
    Table 114. Seqirus Influenza Drugs Product
    Table 115. Seqirus Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 116. Seqirus Recent Development
    Table 117. Protein Sciences Corporation Company Details
    Table 118. Protein Sciences Corporation Business Overview
    Table 119. Protein Sciences Corporation Influenza Drugs Product
    Table 120. Protein Sciences Corporation Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 121. Protein Sciences Corporation Recent Development
    Table 122. Serum Institute of India Company Details
    Table 123. Serum Institute of India Business Overview
    Table 124. Serum Institute of India Influenza Drugs Product
    Table 125. Serum Institute of India Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 126. Serum Institute of India Recent Development
    Table 127. Emergent Biosolutions Company Details
    Table 128. Emergent Biosolutions Business Overview
    Table 129. Emergent Biosolutions Influenza Drugs Product
    Table 130. Emergent Biosolutions Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 131. Emergent Biosolutions Recent Development
    Table 132. BioCryst Pharmaceuticals Company Details
    Table 133. BioCryst Pharmaceuticals Business Overview
    Table 134. BioCryst Pharmaceuticals Influenza Drugs Product
    Table 135. BioCryst Pharmaceuticals Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 136. BioCryst Pharmaceuticals Recent Development
    Table 137. Alvogen Company Details
    Table 138. Alvogen Business Overview
    Table 139. Alvogen Influenza Drugs Product
    Table 140. Alvogen Revenue in Influenza Drugs Business (2016-2021) & (US$ Million)
    Table 141. Alvogen Recent Development
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Influenza Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Oseltamivir Features
    Figure 3. Zanamivir Features
    Figure 4. Peramivir Features
    Figure 5. Other Features
    Figure 6. Global Influenza Drugs Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Pharmacy Case Studies
    Figure 8. Retail Pharmacy Case Studies
    Figure 9. Online Pharmacy Case Studies
    Figure 10. Influenza Drugs Report Years Considered
    Figure 11. Global Influenza Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Influenza Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Influenza Drugs Market Share by Regions: 2020 VS 2027
    Figure 14. Global Influenza Drugs Market Share by Regions (2022-2027)
    Figure 15. Global Influenza Drugs Market Share by Players in 2020
    Figure 16. Global Top Influenza Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Influenza Drugs Revenue in 2020
    Figure 18. Global Influenza Drugs Revenue Market Share by Type (2016-2021)
    Figure 19. Global Influenza Drugs Revenue Market Share by Type (2022-2027)
    Figure 20. North America Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Influenza Drugs Market Share by Type (2016-2027)
    Figure 22. North America Influenza Drugs Market Share by Application (2016-2027)
    Figure 23. North America Influenza Drugs Market Share by Country (2016-2027)
    Figure 24. United States Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Influenza Drugs Market Share by Type (2016-2027)
    Figure 28. Europe Influenza Drugs Market Share by Application (2016-2027)
    Figure 29. Europe Influenza Drugs Market Share by Country (2016-2027)
    Figure 30. Germany Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Influenza Drugs Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Influenza Drugs Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Influenza Drugs Market Share by Region (2016-2027)
    Figure 40. China Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Influenza Drugs Market Share by Type (2016-2027)
    Figure 48. Latin America Influenza Drugs Market Share by Application (2016-2027)
    Figure 49. Latin America Influenza Drugs Market Share by Country (2016-2027)
    Figure 50. Mexico Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Influenza Drugs Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Influenza Drugs Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Influenza Drugs Market Share by Country (2016-2027)
    Figure 56. Turkey Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Influenza Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 60. AstraZeneca Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 61. Eli Lilly Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 63. GlaxoSmithKline Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 64. Novartis Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 65. Pfizer Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 66. Sanofi Pasteur Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 67. Bayer Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 68. Celgene Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 69. Seqirus Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 70. Protein Sciences Corporation Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 71. Serum Institute of India Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 72. Emergent Biosolutions Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 73. BioCryst Pharmaceuticals Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 74. Alvogen Revenue Growth Rate in Influenza Drugs Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure

RELATED REPORTS

China Aprotinin Market Report Forecast 2021 2027
China Aprotinin Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10191
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Aptamers Market Report Forecast 2021 2027
China Aptamers Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-07
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Antipyretic Analgesics Market Report Forecast 2021 2027
China Antipyretic Analgesics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-20T5723
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Artificial Tears Market Report Forecast 2021 2027
China Artificial Tears Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-645
Sat Oct 02 00:00:00 UTC 2021

Add to Cart